Replies to post #4703856 on BB's Stock Haven

[BottomBounce]

$TLRY Tilray and other Canadian marijuana companies go PARABOLIC if the US federal government removes cannabis from the Schedule I drug list. If that happens, Tilray stock will skyrocket. A 2-stage DCF model that sets revenues at $7 billion by 2029 and 40% EBITDA margins puts fair value at over $95, a 1,040% upside.

[BottomBounce]

$TLRY Tilray and other Canadian marijuana companies go PARABOLIC if the US federal government removes cannabis from the Schedule I drug list. If that happens, Tilray stock will skyrocket. A 2-stage DCF model that sets revenues at $7 billion by 2029 and 40% EBITDA margins puts fair value at over $95, a 1,040% upside.